Polly Q. X. Lim

Polly Q. X. Lim

Auto-generated profile, based on publicly available information

Polly Q. X. Lim

Discipline of Podiatry School of Allied Health, Human Services and Sport La Trobe University Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Rheumatology International
Verified
Journal Article
Open access
PDF file
PLPolly Q. X. Lim
Polly Q. X. Lim
MLMerridy J. Lithgow
Merridy J. Lithgow
MKMichelle R. Kaminski
Michelle R. Kaminski
KLKarl B. Landorf
Karl B. Landorf
HMHylton B. Menz
Hylton B. Menz
SMShannon E. Munteanu
Shannon E. Munteanu
This systematic review aims to investigate the efficacy of non-surgical interventions for midfoot osteoarthritis (OA). Key databases and trial registries were searched from inception to 23 February 2023. All trials investigating non-surgical interventions for midfoot OA were included. Quality assessment was performed using the National Institutes of Health Quality Assessment Tool. Outcomes were pain, function, health-related quality of life, and adverse events. Effects (mean differences, standardised mean differences, risk ratios) were calculated where possible for the short (0 to 12 weeks), medium (> 12 to 52 weeks), and long (> 52 weeks) term. Six trials (231 participants) were included (one feasibility trial and five case series) — all were judged to be of poor methodological quality. Two trials reported arch contouring foot orthoses to exert no-to-large effects on pain in the short and medium term, and small-to-very-large effects on function in the short and medium term. Two trials reported shoe stiffening inserts to exert medium-to-huge effects on pain in the short term, and small effects on function in the short term. Two trials of image-guided intra-articular corticosteroid injections reported favourable effects on pain in the short term, small effects on pain and function in the medium term, and minimal long term effects. Two trials reported minor adverse events, and none reported health-related quality of life outcomes. The current evidence suggests that arch contouring foot orthoses, shoe stiffening inserts and corticosteroid injections may be effective for midfoot OA. Rigorous randomised trials are required to evaluate the efficacy of non-surgical interventions for midfoot OA.

1 January 2023 in Journal of Foot and Ankle Research
Verified
Journal Article
Open access
PDF file
HMHylton B. Menz
Hylton B. Menz
PLPolly Q. X. Lim
Polly Q. X. Lim
SHSherre Hurn
Sherre Hurn
KMKaren J. Mickle
Karen J. Mickle
ABAndrew K. Buldt
Andrew K. Buldt
SMShannon E. Munteanu
Shannon E. Munteanu
Background: Hallux valgus is a common and disabling condition. This randomised pilot and feasibility trial aimed to determine the feasibility of conducting a parallel group randomised trial to evaluate the effectiveness of a nonsurgical intervention for reducing pain associated with hallux valgus.Methods: Twenty‐eight community‐dwelling women with painful hallux valgus were randomised to receive either a multifaceted, nonsurgical intervention (footwear, foot orthoses, foot exercises, advice, and self‐management) or usual care (advice and self‐management alone). Outcome measures were obtained at baseline, 4, 8 and 12 weeks. The primary outcome was feasibility, evaluated according to demand (recruitment rate and conversion rate), acceptability, adherence, adverse events, and retention rate. Limited efficacy testing was conducted on secondary outcome measures including foot pain, foot muscle strength, general health‐related quality of life, use of cointerventions, and participants' perception of overall treatment effect.Results: Between July 8, 2021, and April 22, 2022, we recruited and tested 28 participants (aged 44 to 80 years, mean 60.7, standard deviation 10.7). This period encompassed two COVID‐related stay‐at‐home orders (July 16 to July 27, and August 5 to October 21, 2021). The predetermined feasibility thresholds were met for retention rate, foot pain, mental health‐related quality of life, and use of cointerventions, partly met for acceptability, adverse events, and muscle strength, and not met for demand (recruitment rate or conversion rate), adherence, physical health‐related quality of life and perception of overall treatment effect.Conclusion: In its current form, a randomised trial of footwear, foot orthoses, foot exercises, advice and self‐management for relieving pain associated with hallux valgus is not feasible, particularly due to the low adherence with the intervention. However, it is difficult to determine whether the trial would be feasible under different circumstances, particularly due to COVID‐19 stay‐at‐home orders. Future trials will need to consider improving the aesthetics of the footwear and making the exercise program less burdensome.Trial registration: Australian and New Zealand Clinical Trial Registry (ACTRN12621000645853).

2 September 2024 in Journal of Foot and Ankle Research
Verified
Journal Article
Open access
PLPolly Q. X. Lim
Polly Q. X. Lim
HMHylton B. Menz
Hylton B. Menz
KLKarl B. Landorf
Karl B. Landorf
MKMichelle R. Kaminski
Michelle R. Kaminski
ABAndrew K. Buldt
Andrew K. Buldt
SMShannon E. Munteanu
Shannon E. Munteanu
Introduction: Midfoot osteoarthritis (OA) is a painful and disabling condition. Arch contouring foot orthoses have been recommended for midfoot OA, yet there is no high‐quality evidence from randomised controlled trials to support their use. This clinical trial aims to evaluate the efficacy of arch contouring foot orthoses for midfoot OA.Methods: This will be a parallel‐group randomised controlled superiority trial. One‐hundred and forty community‐dwelling people with painful midfoot OA will be randomised to receive either arch contouring foot orthoses or flat sham inserts. Outcome measures will be obtained at baseline, 4, 8 and 12 weeks; the primary endpoint for assessing efficacy being 12 weeks. The primary outcome measure will be average midfoot pain whilst walking over the last 7 days on an 11‐point numerical rating scale. Secondary outcome measures include function (walking/standing subscale of the Manchester–Oxford Foot Questionnaire), participants' perception of overall treatment effect (self‐reported global rating of change on a 15‐point Likert scale), physical activity (Incidental and Planned Exercise Questionnaire), general health‐related quality of life (Short Form‐12 Version® 2.0), use of co‐interventions and adverse events.Discussion: This trial will evaluate the efficacy of arch contouring foot orthoses for relieving pain and improving function, physical activity and health‐related quality of life in people with midfoot OA. The findings will provide high‐quality evidence as to whether arch contouring foot orthoses are efficacious and will help to inform clinical guidelines about the use of foot orthoses for midfoot OA.Trial registration: Australian and New Zealand Clinical Trial Registry (ACTRN12623000953639).

12 May 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
PLPolly Q. X. Lim
Polly Q. X. Lim
HMHylton B. Menz
Hylton B. Menz
KLKarl B. Landorf
Karl B. Landorf
MKMichelle R. Kaminski
Michelle R. Kaminski
KPKade L. Paterson
Kade L. Paterson
SMShannon E. Munteanu
Shannon E. Munteanu
Midfoot osteoarthritis (OA) is a common and disabling condition, yet lacks clinical guidelines for its assessment and management. This study aimed to investigate strategies used by Australian podiatrists to assess and manage midfoot OA. An exploratory cross-sectional survey of podiatrists working in Australia was conducted. Respondents were invited through professional organisations to complete an online questionnaire on their usual assessment and management practices for midfoot OA, based on a vignette. Between November 2022 and July 2023, 103 participants (52% women, mean age 40 years) with an average of 15 years of clinical experience responded. Physical assessments (including history taking and musculoskeletal assessments) (96%) and medical imaging (90%) were commonly used diagnostic methods, with palpation (96%), passive movement testing (95%) and x-ray imaging (62%) frequently reported. Associated impairments were assessed with range of motion testing of the midfoot (96%), gait analysis (95%), functional tests (83%), muscle strength (72%), and observation of static alignment (71%), including foot posture (69%). Most participants assessed comorbidities (93%), body composition (66%) and cognitive/psychosocial impairments (62%). Treatment approaches included footwear advice (97%), orthotic therapy (85%), strapping/taping (81%), education (79%), and exercise therapy (75%). One-third (34%) expected a ‘satisfactory’ treatment response within two months, and 36% would refer to another healthcare practitioner for co-management between two and three months if treatment was ineffective. A wide range of approaches are used to assess and manage midfoot OA. These findings have potential to inform the design of future studies in developing valid assessment approaches and effective interventions for this condition.

12 April 2025 in Journal of Foot and Ankle Research
Verified
Journal Article
Open access
KBKatrina J. Bajraszewski
Katrina J. Bajraszewski
PLPolly Q. X. Lim
Polly Q. X. Lim
ABAndrew K. Buldt
Andrew K. Buldt
SHSherre Hurn
Sherre Hurn
KMKaren J. Mickle
Karen J. Mickle
HMHylton B. Menz
Hylton B. Menz
Background: Narrow fitting footwear is a modifiable risk factor for the development of hallux valgus (HV). Despite this, the pressure that footwear exerts at the medial forefoot has not been fully evaluated in people with HV. Therefore, the objective of this study was to determine whether the toe box of footwear habitually worn by women with HV is associated with pressure exerted on the medial forefoot.Methods: In‐shoe peak pressure and maximum force at the medial forefoot (distal and proximal sites) were recorded from 28 women (mean age 60.7 years, SD 10.7) with moderate or severe HV using the pedar pad pressure system (Novel GmbH, Germany). The shape (width and area) of the participants' most symptomatic foot and toe‐box of their usual footwear was determined using an INFOOT 3D laser scanner (I‐Ware Laboratory, Japan) and hand tracing, respectively. The difference between the foot and corresponding footwear measurements as well as differences in the magnitude and timing of peak pressure and maximum force between the proximal and distal forefoot were determined using independent t‐tests. Correlations between forefoot pressures with toe‐box differential were determined using Spearman's ρ analyses.Results: Peak pressure and maximum force were significantly greater (mean difference [MD] = 33.0 ± 15.4 kPa; p < 0.001 and 12.8 ± 7.3 N; p = 0.001) and occurred slightly later in the stance phase at the distal forefoot compared to the proximal forefoot (MD = 6.0 ± 6.9%; p = 0.083 and 6.9 ± 6.8%; p = 0.045, respectively). There were no significant correlations between toe‐box differential and medial forefoot pressures, with all correlations less than 0.35 (p > 0.05).Conclusion: Toe‐box shape and fit of footwear typically worn by older women with painful HV was not associated with increased medial forefoot pressures in this study sample. Therefore, changing the toe‐box width and area of the usual footwear worn by older women with painful, moderate or severe HV may not necessarily reduce medial forefoot pressures where footwear does not appear to play a role.

2 February 2026 in Journal of Foot and Ankle Research
Verified
Journal Article
Open access
BSBergin Shan
Bergin Shan
PLPolly Q. X. Lim
Polly Q. X. Lim
HMHylton B. Menz
Hylton B. Menz
PTPeta E. Tehan
Peta E. Tehan
MCMatthew R. Carroll
Matthew R. Carroll
Background: To conduct a bibliographic analysis of English language foot and ankle research pertaining to rheumatology published by Australian authors. Methods: The Scopus database search was conducted to identify all Australian rheumatology articles published by podiatric authors in English from 1970 to 2024. Bibliometric analysis was performed using an open‐source tool based on the R language. Citations, journals, authors, institutions and countries were described. Publications were manually categorised according to research type, level of evidence and funding source. Results: The search strategy yielded 89 eligible articles, which received a total of 2438 citations and were published by 200 authors. The most frequent journals were Arthritis Care & Research and Osteoarthritis and Cartilage each with 9 articles or 10% of total publications. The most published institution was La Trobe University (affiliation of 151 authors). Most of the Australian rheumatology articles focused on the evaluation of treatments and therapeutic interventions ( n = 35; 39%) and 11 articles (12%) provided Level I evidence. Forty‐two publications (47%) were supported by Category 1 funding, however, 29 (33%) reported no research funding. Conclusion: Rheumatology represents just 5% of Australian podiatry research. Despite this, it attracts high citation rates relative to number of publications and is well supported by Category 1 funding in comparison to other research fields. Funding sources outside of competitive Category 1 grants appear to be limited however, and research scope is narrow with a high number of evaluative studies conducted. Rheumatology research would benefit from an increase in available funding sources and a broader research scope that informs disease prevention and evidence‐based clinical care.